Leszek Lisowski
Consultant / Advisor presso 4BIO Ventures Management Ltd.
Profilo
Leszek Lisowski founded LogicBio Therapeutics, Inc. in 2014, where he worked as President & Chief Executive Officer.
Dr. Lisowski also currently works at 4BIO Ventures Management Ltd., as Advisor.
Dr. Lisowski also formerly worked at The Salk Institute for Biological Studies, as Director from 2013 to 2015.
Dr. Lisowski received his doctorate degree in 2008 from Cornell University, undergraduate degree in 2001 from the University of Bridgeport, and Masters Business Admin degree in 2015 from the University of California San Diego.
Posizioni attive di Leszek Lisowski
| Società | Posizione | Inizio |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Consultant / Advisor | - |
Precedenti posizioni note di Leszek Lisowski
| Società | Posizione | Fine |
|---|---|---|
| The Salk Institute for Biological Studies | Director/Board Member | 01/10/2015 |
| LOGICBIO THERAPEUTICS, INC. | Chief Executive Officer | - |
Formazione di Leszek Lisowski
| Cornell University | Doctorate Degree |
| University of Bridgeport | Undergraduate Degree |
| University of California San Diego | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Leszek Lisowski
